Introduction
Pain and inflammatory conditions affect large proportions of patients in both high and lower income countries, especially in females and those of older age (Tsang et al., 2008) . NSAIDs are important for the management of these conditions, acting by inhibition of the cyclooxygenase (COX) enzymes, and are widely used in the community (Rao & Knaus, 2008; Brune and Patrignani, 2015) . NSAIDs can potentially induce significant complications involving the gastro-intestinal (GI), cardiovascular (CV) and renal systems (Wehling, 2014) .
NSAID use is widespread and all healthcare professionals have a duty to identify whether patients have factors potentially increasing the risk of adverse effects before supplying them. In practice, however, studies in several countries show frequent prescribing of NSAIDs in patients with risk factors such as diabetes, hypertension, heart diseases, GI problems (AlShidhani et al., 2015) , chronic kidney disease (Ingrasciotta et al., 2014; Meuwesen et al., 2016) . Their use is also common in older patients (Hanlon et al., 2002) and in combination with drugs likely to cause serious drug-drug interactions (Hersh et al., 2007) . Furthermore, patients' awareness of the risks of NSAIDs is lower than desirable (Wilcox et al., 2005; Cullen et al., 2006; Stosic et al., 2011) and their perceptions concerning these risks is much lower than that of healthcare professionals (Bongard et al., 2002; Cullen et al., 2006) . The lack of knowledge about possible adverse drug reactions (ADRs) may be influenced by the ease with which NSAIDs can be purchased (Cullen et al., 2006) . Community pharmacies are an important source of NSAID supply, so pharmacists should screen potential purchasers and those presenting prescriptions (Mangum et al., 2003) for risk factors and provide safety information about these products. Community pharmacybased interventions in relation to NSAIDs can prevent serious long-term problems, including acute kidney injury (Pai, 2015) and gastrointestinal complications (Ibañez-Cuevas et al., 2008; Teichert et al., 2014) , as well as impacting positively on patient knowledge (Jang et al., 2011). 4 In Thailand, NSAIDs were the second most frequently reported drugs in the spontaneous reporting system for ADRs between 1984 and 2017 (Health Product Vigilance Center, 2018 . National health surveys found that 20% of people take a painkiller 2-3 days per week including NSAIDs (Akepalakorn, 2009) . Moreover, a recent study reported that 30% of people in rural areas use NSAIDs often (Luanghirun et al., 2017) . The prevalence of NSAID use in Thailand is similar to that in the United States (Zhou et al., 2014) , but Thai patients can obtain NSAIDs without prescription from pharmacies, even those not classified as over the counter (OTC) drugs in Thailand. Unlike many countries, Thailand has no guidelines concerning risk screening and information provision to inform best practice for pharmacists.
Moreover, little work has studied the practices of community pharmacists in Thailand. Our previous survey in Thai hospital out-patients found they had poor knowledge about the risks of taking NSAIDs (Phueanpinit et al., 2016) . Hence this survey aimed to determine community pharmacists' self-reported practices in screening patients for risk factors prior to supplying NSAIDs and providing information about potential ADRs and their management.
Methods

Study design and setting
A cross-sectional survey involving community pharmacists was carried out in Thailand over a 5-month period. Community pharmacists may work in pharmacies or be pharmacy owners.
The total number of pharmacies allowed to operate by the Thai Food and Drug Administration (Thai FDA) was obtained from The Bureau of Drug Control, Ministry of Public Health. From a total of 10,176 pharmacies in Thailand, 406 (4%) pharmacies were certificated as being 'accredited'. An accredited pharmacy is one which has attained a mark of quality awarded by the Pharmacy Council, which requires they conform to five important criteria in addition to general mandatory control by the Thai FDA. These are: accessible location close to primary 5 health care centres, equipment, personnel, professional ethics and good quality pharmaceutical services, including screening, diagnosis and counselling. The standard of practice in these pharmacies is thus higher than in non-accredited pharmacies and importantly also requires that a pharmacist is present on site at all times (which is not the case for non-accredited pharmacies).
Therefore, as there is no guarantee that a pharmacist would be able to respond to the survey in non-accredited pharmacies, this study involved only accredited pharmacies.
Questionnaire development
A questionnaire was developed in two parts; demographic data (sex, age, educational level, work experience, type of pharmacy, pharmacy owner, number of staff in pharmacy, number of patients per day, working time, have internship program) and pharmacists' role in supplying NSAIDs. The latter section consisted of nine questions covering: screening patients at risk, assessment of the necessity for using NSAIDs, communicating potential adverse effects, advice on how to manage and prevent ADRs, asking about current drug use, herbs and supplements, and advice on the things that patients should or should not do while taking NSAIDs. Each question provided options related to frequency of practice (regularly, occasionally, or never), plus, for those indicating they provide screening risk of ADRs, ADR communication, and ADR management, additional details were requested. Content validity was conducted by three pharmacists, and the questionnaire was subsequently piloted in ten community pharmacists working in non-accredited pharmacies.
Data collection
A questionnaire with covering letter explaining the objectives of study was sent to all 406 community pharmacies by mail: 39 located in the northern region, 67 in the northeastern region, 34 in the eastern region, 12 in the western region, 59 in southern region, and 195 in the central region. The pharmacists in charge were requested to return the questionnaire within 3 6 weeks. If the questionnaire was not returned within two weeks, reminder cards were sent to non-respondents.
Statistical analysis
The data from returned questionnaires were analysed using IBM SPSS version 19.0. Frequency of practice was dichotomised into regular and not regular. Chi-square test, Fisher's exact test and Independent t-test were used to explore the associations between demographic variables and roles in screening for risk factors, providing ADR information, and ADR management related to NSAIDs, where appropriate.
Results
Response rate and demographic details
From the 406 questionnaires distributed, 159 were returned and analysable (response rate 39.2%). The majority of respondents were working in independently-owned pharmacies (N=114, 71.7%), and were female (N=104, 65.4%). The average age was 37.2 ± 11.42 years (range 23 to 73 years). More than half the pharmacists had more than 5 years practice experience in community pharmacy (N=92, 57.9%). Just over half were pharmacy owners (N=90, 56.6%) and most pharmacies were located in urban areas (N=125, 78.6%). Other characteristics are shown in Table 1 .
(Insert Table 1) The frequency of community pharmacists' self-reported practice roles in supplying NSAIDs are illustrated in Table 2 . Almost all claimed to regularly or occasionally determine the need for an NSAID and explain to patients what they should or should not do while using NSAIDs. Less than a third claimed to seek information about concomitant drugs and supplements on a regular basis. While all claimed to screen patients for risk factors before 7 supplying non-selective NSAIDs, the proportion indicating doing so was slightly lower for supply of selective COX-2 NSAIDs (N=146, 96.7%).
(Insert Table 2) Similarly, fewer indicated that they regularly communicated about ADR and provided advice on managing and preventing adverse effects s of selective NSAIDs compared to nonselective NSAIDs. Details of the screening which community pharmacists claimed to perform before dispensing are presented in Table 3 , which differed slightly between the two classes of NSAID. In univariate analysis, no significant factor was related to screening practices for NSAID risks.
(Insert Table 3 )
Provision of NSAID information and ADR-management
Differences in reported provision of information regarding potential ADRs and how to prevent or manage them were also found for the different classes of NSAID. For non-selective NSAIDs, pharmacists claimed to provide information most frequently about GI ulcer (N=144, 95.4%) and GI bleeding (N=97, 64.2%), but for selective NSAIDs, the most common ADRs mentioned were CV events (N=100, 74.1%), with other potential ADRs being mentioned by fewer than half, including high blood pressure (N=48, 35.6%). For non-selective NSAIDs, pharmacists' most common advice for preventing GI problems was to take after meals (N=138, 94.5%), but many also claimed they would advise patients to use gastro-protective agents (N=98, 67.1%), switch to selective NSAIDs (N=91, 62.3%), or use other painkillers (N=79, 54.1%). However, for selective NSAIDs, the most frequent advice given was to switch to other painkillers (N=95, 67.4%), use a gastro-protective agent (N=73, 51.8%) or see a doctor (N=68, 48.2%).
(Insert Table 4 (OR 3.18, ). In contrast, pharmacists who had assistants were significantly less likely to inform about ADRs to selective NSAID users (OR 0.41, ). However, there were no statistically significant factors which influenced the provision of ADR-management to patients.
(Insert Table 5 2009), therefore patients should usually be advised to use them at low dose and for short duration, however, these basic points of information for preventing ADRs were not reported by our Thai community pharmacist respondents.
Community pharmacists in Thailand are the main source of supply of NSAIDs and it is essential that all patients obtaining them are aware of the potential risks. Despite accredited pharmacies having high quality services guaranteed by the Pharmacy Council, this study found that patients may still not receive the desirable comprehensive service from these pharmacies in relation to these widely used medicines, which it is known result in many ADRs (Health Product Vigilance Center, 2018). Greater effort is needed to ensure that community pharmacy services in Thailand contribute more to the safe use of medicines, such as NSAIDs. Studies in other countries show that the public trust NSAIDs, regarding them as harmless, particularly OTC NSAIDs, few believe themselves to have any risk factors for using these drugs, and show a lack of concern about potential adverse effects (Wilcox et al., 2005) . Pharmacists could increase awareness of NSAID risks among their patients, carry out screening and evaluate patient risk factors and provide information to patients to ensure appropriate, safe use of these drugs.
Limitations of the study
Our study only included pharmacists who work in accredited pharmacies, which may be expected to provide better quality services than the non-accredited pharmacies constituting the large majority of pharmacies in Thailand. In addition, the response rate was approximately 40% and no data were obtained about non-responding pharmacies. Therefore our results cannot be extrapolated to non-accredited pharmacies or to all accredited pharmacies across Thailand.
It is likely that the proportion of pharmacists who do provide screening and information to patients may be considerably lower than our results suggest. Social desirability and recall bias may have occurred, in addition, the self-completed questionnaire required pharmacists to selfreport the frequency of their practices using only three options (regularly, occasionally, or never).
Conclusion
Risk screening and provision of ADR information and management for patients using NSAIDs was not universal practice in Thai accredited community pharmacists. Thus patients may be at risk of ADRs from NSAIDs obtained from pharmacies and they are also not fully informed about potential ADRs. Greater attention should be paid to the provision of medication safety information about NSAIDs by community pharmacists, particularly in patients who use these drugs long-term and those at high risk of ADRs. 
